晚期癌症患者的长期参与:EPAC随机临床试验的结果
Manali I Patel1,2, Madhuri Agrawal2, Douglas W Blayney1
1Department of Medicine, Stanford University School of Medicine, Stanford, California.
JAMA oncology
|May 30, 2024
概括
由非专业卫生工作者领导的预先护理规划干预措施显著降低了晚期癌症患者的死亡风险和医疗费用. 这项长期研究显示了干预措施.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 对癌症患者来说,提前护理规划至关重要.
- 非专业卫生工作者主导的干预措施的长期影响尚未得到充分证实.
研究的目的:
- 评估非专业卫生工作者主导的预先护理计划干预措施的长期影响.
- 评估对晚期癌症患者的整体存活率,医疗保健利用率和成本的影响.
主要方法:
- 随机临床试验 (EPAC) 的后续情况.
- 包括213名患有3-4期或复发性癌症的患者.
- 干预涉及一个为期6个月的非专业卫生工作者领导的教育和支持计划与通常的护理.
主要成果:
- 干预组显示死亡风险降低了25%.
- 更多地使用息治疗和临终关怀.
- 减少了急诊室的访问,住院和医疗保健总成本.
结论:
- 由非专业卫生工作者领导的预先护理规划干预表明了持久的好处.
- 支持将其整合到常规癌症护理中,以改善患者的治疗结果和成本效益.
相关概念视频
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Patient-centered Care
2.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


